Literature DB >> 23968874

A surge of MDR and XDR tuberculosis in France among patients born in the Former Soviet Union.

C Bernard1, F Brossier, W Sougakoff, N Veziris, M Frechet-Jachym, N Metivier, A Renvoisé, J Robert, V Jarlier.   

Abstract

A marked increase in the number of multidrug-resistant (MDR) tuberculosis (TB) cases entirely related to patients born in the Former Soviet Union was observed in France in the last two years. Very few cases were clustered, suggesting it is a consequence of recent immigration of patients already infected in their country of origin. This major increase challenges the existing structures for management of MDR and extensively drug-resistant TB (XDR-TB).

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23968874     DOI： 10.2807/1560-7917.es2013.18.33.20555

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  11 in total

1.  Molecular diagnosis of fluoroquinolone resistance in Mycobacterium tuberculosis.

Authors:  Christine Bernard; Nicolas Veziris; Florence Brossier; Wladimir Sougakoff; Vincent Jarlier; Jérôme Robert; Alexandra Aubry
Journal:  Antimicrob Agents Chemother       Date:  2014-12-22       Impact factor: 5.191

2.  Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries.

Authors:  L Guglielmetti; C Hewison; Z Avaliani; J Hughes; N Kiria; N Lomtadze; N Ndjeka; S Setkina; A Shabangu; W Sikhondze; A Skrahina; N Veziris; J Furin
Journal:  Int J Tuberc Lung Dis       Date:  2017-02-01       Impact factor: 2.373

3.  Map the gap: missing children with drug-resistant tuberculosis.

Authors:  C M Yuen; C A Rodriguez; S Keshavjee; M C Becerra
Journal:  Public Health Action       Date:  2015-03-21

4.  Risk factors associated with loss to follow-up among multidrug-resistant tuberculosis patients in Georgia.

Authors:  G Kuchukhidze; A M V Kumar; P de Colombani; M Khogali; U Nanava; H M Blumberg; R R Kempker
Journal:  Public Health Action       Date:  2014-10-21

Review 5.  Towards tuberculosis elimination: an action framework for low-incidence countries.

Authors:  Knut Lönnroth; Giovanni Battista Migliori; Ibrahim Abubakar; Lia D'Ambrosio; Gerard de Vries; Roland Diel; Paul Douglas; Dennis Falzon; Marc-Andre Gaudreau; Delia Goletti; Edilberto R González Ochoa; Philip LoBue; Alberto Matteelli; Howard Njoo; Ivan Solovic; Alistair Story; Tamara Tayeb; Marieke J van der Werf; Diana Weil; Jean-Pierre Zellweger; Mohamed Abdel Aziz; Mohamed R M Al Lawati; Stefano Aliberti; Wouter Arrazola de Oñate; Draurio Barreira; Vineet Bhatia; Francesco Blasi; Amy Bloom; Judith Bruchfeld; Francesco Castelli; Rosella Centis; Daniel Chemtob; Daniela M Cirillo; Alberto Colorado; Andrei Dadu; Ulf R Dahle; Laura De Paoli; Hannah M Dias; Raquel Duarte; Lanfranco Fattorini; Mina Gaga; Haileyesus Getahun; Philippe Glaziou; Lasha Goguadze; Mirtha Del Granado; Walter Haas; Asko Järvinen; Geun-Yong Kwon; Davide Mosca; Payam Nahid; Nobuyuki Nishikiori; Isabel Noguer; Joan O'Donnell; Analita Pace-Asciak; Maria G Pompa; Gilda G Popescu; Carlos Robalo Cordeiro; Karin Rønning; Morten Ruhwald; Jean-Paul Sculier; Aleksandar Simunović; Alison Smith-Palmer; Giovanni Sotgiu; Giorgia Sulis; Carlos A Torres-Duque; Kazunori Umeki; Mukund Uplekar; Catharina van Weezenbeek; Tuula Vasankari; Robert J Vitillo; Constantia Voniatis; Maryse Wanlin; Mario C Raviglione
Journal:  Eur Respir J       Date:  2015-04       Impact factor: 16.671

6.  Multi drug and other forms of drug resistant tuberculosis are uncommon among treatment naïve tuberculosis patients in Tanzania.

Authors:  Tumaini J Nagu; Said Aboud; Ramadhani Mwiru; Mecky Matee; Wafaie Fawzi; Ferdinand Mugusi
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

7.  Linezolid in the Starter Combination for Multidrug-Resistant Tuberculosis: Time to Move on to Group Four?

Authors:  Soazic Grard; Gaud Catho; Florent Valour; Anissa Bouaziz; Thomas Perpoint; Evelyne Braun; François Biron; Patrick Miailhes; Tristan Ferry; Christian Chidiac; Pierre-Jean Souquet; Sébastien Couraud; Gérard Lina; Sylvain Goutelle; Nicolas Veziris; Oana Dumitrescu; Florence Ader
Journal:  Open Forum Infect Dis       Date:  2015-12-22       Impact factor: 3.835

8.  Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009-2014.

Authors:  Benoît Henry; Matthieu Revest; Nathalie Dournon; Loïc Epelboin; Guillaume Mellon; Guillaume Bellaud; Pierre Mordant; Damien Le Dû; Nicolas Véziris; Christine Bernard; Sébastien Morel; Stéphane Jauréguiberry; Christian Michelet; Françcois Bricaire; Pierre Tattevin; Éric Caumes
Journal:  Emerg Infect Dis       Date:  2016-03       Impact factor: 6.883

9.  Microbial molecular markers and epidemiological surveillance in the era of high throughput sequencing: an update from the IMMEM-10 conference.

Authors:  Sylvain Brisse; Carina Brehony; Teresa Conceição; Meritxell Cubero; Corinna Glasner; Meriadeg Le Gouil; Aurélie Renvoisé; Sam Sheppard; Lucy A Weinert
Journal:  Res Microbiol       Date:  2014-01-31       Impact factor: 3.992

10.  Combined Genotypic, Phylogenetic, and Epidemiologic Analyses of Mycobacterium tuberculosis Genetic Diversity in the Rhône Alpes Region, France.

Authors:  Catherine Pichat; David Couvin; Gérard Carret; Isabelle Frédénucci; Véronique Jacomo; Anne Carricajo; Sandrine Boisset; Oana Dumitrescu; Jean-Pierre Flandrois; Gérard Lina; Nalin Rastogi
Journal:  PLoS One       Date:  2016-04-29       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.